NR3C2 and hydrops fetalis: Importantly, aldosterone receptor blockade or mineralocorticoid receptor antagonism with the use of spironolactone or eplerenone reduces morbidity and mortality in patients with HF, including the elderly subgroup; this beneficial effect is more pronounced in patients with HFrEF, albeit it remains homogenous across HFrEF and HFpEF [68].